Paper8902255
Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.
Diener HC and 8 others. Cephalalgia, 1996. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group. Papers, record 8902255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8902255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclandelate | Major topic |
| Migraine Disorders | Major topic |
| Propranolol | Major topic |
| Vasodilator Agents | Major topic |
| Adult | |
| Dose-Response Relationship, Drug | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pain Measurement | |
| Treatment Outcome |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40978493 | Oral preventive medications for migraine in adults aged 18-65: a network meta-analysis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40978493 | PubMed |
| 39044170 | European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol. | J Headache Pain | 2024 | https://conductscience.org/library/papers/39044170 | PubMed |
| 38110000 | High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis. | Adv Nutr | 2024 | https://conductscience.org/library/papers/38110000 | PubMed |
| 37208596 | The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. | J Headache Pain | 2023 | https://conductscience.org/library/papers/37208596 | PubMed |
| 37193973 | The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression. | J Headache Pain | 2023 | https://conductscience.org/library/papers/37193973 | PubMed |
| 34696711 | CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs. | J Headache Pain | 2021 | https://conductscience.org/library/papers/34696711 | PubMed |
| 30893319 | Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis. | PLoS One | 2019 | https://conductscience.org/library/papers/30893319 | PubMed |
| 28220376 | Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis. | J Headache Pain | 2017 | https://conductscience.org/library/papers/28220376 | PubMed |
| 28212466 | WITHDRAWN: Propranolol for migraine prophylaxis. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28212466 | PubMed |
| 26839703 | Evidence-Based Treatments for Adults with Migraine. | Pain Res Treat | 2015 | https://conductscience.org/library/papers/26839703 | PubMed |
| 26172390 | A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. | PLoS One | 2015 | https://conductscience.org/library/papers/26172390 | PubMed |
| 20880898 | Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. | BMJ | 2010 | https://conductscience.org/library/papers/20880898 | PubMed |
| 20169042 | Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference. | Neuropsychiatr Dis Treat | 2010 | https://conductscience.org/library/papers/20169042 | PubMed |
| 19209286 | Optimizing prophylactic treatment of migraine: Subtypes and patient matching. | Ther Clin Risk Manag | 2008 | https://conductscience.org/library/papers/19209286 | PubMed |
| 18806984 | [Alternatives to beta blockers in preventive migraine treatment]. | Nervenarzt | 2008 | https://conductscience.org/library/papers/18806984 | PubMed |
| 15581385 | The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care. | CNS Drugs | 2004 | https://conductscience.org/library/papers/15581385 | PubMed |
| 9829155 | A practical guide to the management and prevention of migraine. | Drugs | 1998 | https://conductscience.org/library/papers/9829155 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8902255
GET https://conductscience.org/api/papers/v1/8902255/authors